Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies.
Vaccines for protection against respiratory infections should optimally induce a mucosal immune response in the respiratory tract in addition to a systemic immune response. However, current parenteral immunization modalities generally fail to induce mucosal immunity, while mucosal vaccine delivery o...
Main Authors: | Heng Liu, Harshad P Patil, Jacqueline de Vries-Idema, Jan Wilschut, Anke Huckriede |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3729563?pdf=render |
Similar Items
-
Enhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100.
by: Heng Liu, et al.
Published: (2012-01-01) -
Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation
by: Harshad P. Patil, et al.
Published: (2017-07-01) -
Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations
by: Gabriela Tapia-Calle, et al.
Published: (2017-08-01) -
The evolution of humoral immune responses to past and novel influenza virus strains gives evidence for antigenic seniority
by: Federica Sicca, et al.
Published: (2022-09-01) -
Immunization strategies to elicit mucosal immune response of HIV
by: Shi Yinghui
Published: (2006-12-01)